PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
132 hedge funds and large institutions have $310M invested in PDL BioPharma, Inc. in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 29 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
12% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 26
41% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 49
Holders
132
Holding in Top 10
3
Calls
$302K
Puts
$78K
Top Buyers
| 1 | +$28.9M | |
| 2 | +$10.4M | |
| 3 | +$4.8M | |
| 4 |
WFI
West Family Investments
Carlsbad,
California
|
+$2.08M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.65M |
Top Sellers
| 1 | -$7.79M | |
| 2 | -$4.38M | |
| 3 | -$4.13M | |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$3.88M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$2.53M |